Landis MN, Arya M, Smith S, Draelos Z, et al. Efficacy and safety of topical brepocitinib for the treatment of mild-to-moderate atopic dermatitis: a phase IIb, randomised, double-blind, vehicle-controlled, dose-ranging, and parallel-group study. Br J Dermatol 2022 Aug 20. doi: 10.1111/bjd.21826.
PMID: 35986699